| Aug 8 |
Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
|
| Aug 8 |
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
|
| Aug 7 |
Insulet Q2 2024 Earnings Preview
|
| Aug 5 |
Unlocking Q2 Potential of Insulet (PODD): Exploring Wall Street Estimates for Key Metrics
|
| Aug 1 |
Insulet (PODD) Earnings Expected to Grow: Should You Buy?
|
| Jul 31 |
Is It Time To Consider Buying Insulet Corporation (NASDAQ:PODD)?
|
| Jul 30 |
EYE vs. PODD: Which Stock Is the Better Value Option?
|
| Jul 26 |
Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?
|
| Jul 26 |
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
|
| Jul 26 |
Insulet's prelim Q2 revenue tops estimates
|
